Clinical Trial Update: Study of Low Intensity Conditioning and Immunotherapy for High-Risk Cancers of the Blood [Phase 2]

View source ↗

Summary

This is a Phase 2 trial update evaluating low-intensity conditioning and immunotherapy for high-risk blood cancers; the study has been terminated.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Leukemia
• Multiple Myeloma
• Myelodysplastic Syndromes
• Non-hodgkin Lymphoma

Snippet

Sponsor: University of Michigan Rogel Cancer Center | Conditions: Leukemia, Lymphoma, Low-Grade | Phase 2 | Status: TERMINATED